BACKGROUND: Mild (MCI) and Subjective Cognitive Impairment (SCI) are conditions at risk of developing Alzheimer's disease (AD). Differential between normal aging at early stages can be really challenging; available biomarkers need to be combined and can be quite invasive and expensive. OBJECTIVE: The aim of this pilot study is to examine possible EEG alterations in MCI and SCI compared to controls, analyzing if a cognitive task could highlight early AD hallmarks. METHOD: We recruited 11 MCI, 8 SCI and 7 healthy subjects as controls (CS), all matched for age and education. Neuropsychological assessment and EEG recording, at resting state and during a mental memory task, were performed. Classical spectral measures and nonlinear parameters w...
Item does not contain fulltextNew treatments for Alzheimer's disease require early detection of cogn...
To access publisher's full text version of this article click on the hyperlink belowBACKGROUND: Quan...
New treatments for Alzheimer's disease require early detection of cognitive decline. Most studies se...
Alzheimer's disease (AD) pathological changes may begin up to decades earlier than the appearance of...
AbstractMCI is a clinical state intermediate between elderly normal cognition and dementia featuring...
This is the final version. Available from Nature Research via the DOI in this record. The dynamics o...
Amnestic Mild Cognitive Impairment (aMCI) has been proposed as a diagnostic category for the transit...
In this paper, we explore the utility of resting-state EEG measures as potential biomarkers for the ...
Early and effective diagnosis is critical in the prevention of Alzheimer’s disease (AD); however, ro...
In this study, we investigated the ability of commonly used neuropsychological tests to detect cogni...
This thesis concerns the investigation of mild cognitive impairment (MCI) and Alzheimer's disease (A...
Objective: We aimed at investigating alterations in Resting-State electroencephalography (rsEEG) pat...
International audienceAbstract Early biomarkers are needed to identify individuals at high risk of p...
Subjective memory complaints (SMCs) have been related to subtle cognitive deficits and neural change...
The rapid increase in the number of older people with Alzheimer's disease (AD) and other forms of de...
Item does not contain fulltextNew treatments for Alzheimer's disease require early detection of cogn...
To access publisher's full text version of this article click on the hyperlink belowBACKGROUND: Quan...
New treatments for Alzheimer's disease require early detection of cognitive decline. Most studies se...
Alzheimer's disease (AD) pathological changes may begin up to decades earlier than the appearance of...
AbstractMCI is a clinical state intermediate between elderly normal cognition and dementia featuring...
This is the final version. Available from Nature Research via the DOI in this record. The dynamics o...
Amnestic Mild Cognitive Impairment (aMCI) has been proposed as a diagnostic category for the transit...
In this paper, we explore the utility of resting-state EEG measures as potential biomarkers for the ...
Early and effective diagnosis is critical in the prevention of Alzheimer’s disease (AD); however, ro...
In this study, we investigated the ability of commonly used neuropsychological tests to detect cogni...
This thesis concerns the investigation of mild cognitive impairment (MCI) and Alzheimer's disease (A...
Objective: We aimed at investigating alterations in Resting-State electroencephalography (rsEEG) pat...
International audienceAbstract Early biomarkers are needed to identify individuals at high risk of p...
Subjective memory complaints (SMCs) have been related to subtle cognitive deficits and neural change...
The rapid increase in the number of older people with Alzheimer's disease (AD) and other forms of de...
Item does not contain fulltextNew treatments for Alzheimer's disease require early detection of cogn...
To access publisher's full text version of this article click on the hyperlink belowBACKGROUND: Quan...
New treatments for Alzheimer's disease require early detection of cognitive decline. Most studies se...